Cel-sci corporation to present at ld micro "main event" investor conference

Vienna, virginia--(newsfile corp. - october 10, 2025) - cel-sci corporation (nyse american: cvm), a clinical stage cancer immunotherapy company, today announced that geert kersten, chief executive officer, is scheduled to present at the ld micro "main event" investor conference on october 21, 2025 at 9:30 a.m. pst. the conference is taking place at the hotel del coronado in san diega, ca from october 19-21, 2025.
SCI Ratings Summary
SCI Quant Ranking